Latest Report Available at Orbis research RNAi for Therapeutic Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.
Request sample copy of this report @ http://www.orbisresearch.com/contacts/request-sample/378969 .
This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in RNAi for Therapeutic industry.
This report splits RNAi for Therapeutic market By Technology, By Molecular Form, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022.
This report focuses Global market, it covers details as following:
Major Companies
Alnylam Pharmaceuticals (USA)
Arbutus Biopharma (Tekmira) (Canada)
Arrowhead Research (USA)
Dicerna Pharmaceuticals (USA)
Mirna Therapeutics (USA)
Quark Pharmaceuticals (Israel)
RXi Pharmaceuticals (USA)
Silence Therapeutics (Germany)
Benitec Biopharma (Australia)
miRagen Therapeutics (USA)
Sylentis (Spain)
Gradalis (USA)
Sirnaomics (USA)
Silenseed (Israel)
Arcturus Therapeutics (USA)
Arcturus Therapeutics (USA)
Ariz Biopharma (USA)
GeneCopoeia (USA)
Ascletis Pharmaceuticals (USA)
Celsion Corporation (USA)
Astellas Pharma (USA)
AstraZeneca (UK)
BioSpring (Vietnam)
Calando Pharmaceuticals (USA)
Celgene (USA)
Bayer Heathcare (USA)
Biogazelle (Belgium)
CombiMatrix (USA)
Creative Animodel (USA)
Ensysce Biosciences (USA)
Browse Complete Report @ http://www.orbisresearch.com/reports/index/global-rnai-for-therapeutic-detailed-analysis-report-2017-2022 .
Main Regions
North America
United States
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others
Purchase a copy of RNAi for Therapeutic Market visit @ http://www.orbisresearch.com/contact/purchase/378969 For more information contact sales@orbisresearch.com .
Main Product Type
RNAi for Therapeutic Market, by Technology
siRNA
miRNA
shRNA
RNAi for Therapeutic Market, by Molecular Form
Single Chain
Double Chain
Main Applications
Cancer
Cardiovascular
HBV
Other
Some points from TOC:
Chapter One: RNAi for Therapeutic Market Overview
1.1 Global RNAi for Therapeutic Market Sales Volume Revenue and Price 2012-2022
1.2 RNAi for Therapeutic, By Technology 2012-2022
1.2.1 Global RNAi for Therapeutic Sales Market Share by Technology 2012-2022
1.2.2 Global RNAi for Therapeutic Revenue Market Share by Technology 2012-2022
1.2.3 Global RNAi for Therapeutic Price by Technology 2012-2022
1.2.4 siRNA
1.2.5 miRNA
1.2.6 shRNA
1.3 RNAi for Therapeutic, by Molecular Form 2012-2022
1.3.1 Global RNAi for Therapeutic Sales Market Share by Molecular Form 2012-2022
1.3.2 Global RNAi for Therapeutic Revenue Market Share by Molecular Form 2012-2022
1.3.3 Global RNAi for Therapeutic Price by Molecular Form 2012-2022
1.3.4 Single Chain
1.3.5 Double Chain
Chapter Two: RNAi for Therapeutic by Regions 2012-2017
2.1 Global RNAi for Therapeutic Sales Market Share by Regions 2012-2017
2.2 Global RNAi for Therapeutic Revenue Market Share by Regions 2012-2017
2.3 Global RNAi for Therapeutic Price by Regions 2012-2017
2.4 North America
2.4.1 United States
2.4.2 Canada
2.5 Latin America
2.5.1 Mexico
2.5.2 Brazil
2.5.3 Argentina
2.5.4 Others in Latin America
2.6 Europe
2.6.1 Germany
2.6.2 United Kingdom
2.6.3 France
2.6.4 Italy
2.6.5 Spain
2.6.6 Russia
2.6.7 Netherland
2.6.8 Others in Europe
2.7 Asia & Pacific
2.7.1 China
2.7.2 Japan
2.7.3 India
2.7.4 Korea
2.7.5 Australia
2.7.6 Southeast Asia
2.7.6.1 Indonesia
2.7.6.2 Thailand
2.7.6.3 Philippines
2.7.6.4 Vietnam
2.7.6.5 Singapore
2.7.6.6 Malaysia
2.7.6.7 Others in Southeast Asia
2.8 Africa & Middle East
2.8.1 South Africa
2.8.2 Egypt
2.8.3 Turkey
2.8.4 Saudi Arabia
2.8.5 Iran
2.8.6 Others in Africa & Middle East
Chapter Three: RNAi for Therapeutic by Players 2012-2017
3.1 Global RNAi for Therapeutic Sales Volume Market Share by Players 2012-2017
3.2 Global RNAi for Therapeutic Revenue Share by Players 2012-2017
3.3 Global Top Players RNAi for Therapeutic Key Product Model and Market Performance
3.4 Global Top Players RNAi for Therapeutic Key Target Consumers and Market Performance
Chapter Four: RNAi for Therapeutic by Consumer 2012-2017
4.1 Global RNAi for Therapeutic Sales Market Share by Consumer 2012-2017
4.2 Cancer
4.3 Cardiovascular
4.4 HBV
4.5 Other
4.6 Consuming Habit and Preference
For any enquires before buying, connect with us @ enquiry@orbisresearch.com
About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019
Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research
Follow us on Twitter: https://twitter.com/orbisresearch
Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115
No comments:
Post a Comment